Claremont BioSolutions Awarded $3M Phase II SBIR NIH Grant

Claremont BioSolutions announces the award of a $3M Phase II SBIR NIH grant to further develop a sample preparation and detection cartridge for Clostridium difficile.

(PRWeb July 16, 2012)

Read the full story at http://www.prweb.com/releases/2012/7/prweb9696471.htm

Click here for reuse options!
Copyright 2012 Biotechblog

Comments are closed.

%d bloggers like this: